Literature DB >> 6388326

Potassium homeostasis and clinical implications.

R S Brown.   

Abstract

The clinical estimation of potassium balance generally depends on the level of serum potassium. Since the extracellular fluid contains only 2 percent of the total body potassium, it must be recognized that potassium deficits are usually large before significant hypokalemia occurs, whereas smaller surfeits of potassium will cause hyperkalemia. The total body potassium is regulated by the kidney in which distal nephron secretion of potassium into the urine is enhanced by aldosterone, alkalosis, adaptation to a high potassium diet, and delivery of increased sodium and tubular fluid to the distal tubule. However, the distribution of potassium between the intracellular and extracellular fluids can markedly affect the serum potassium level without a change in total body potassium. Cellular uptake of potassium is regulated by insulin, acid-base status, aldosterone, and adrenergic activity. Hypokalemia, therefore, may be caused by redistribution of potassium into cells due to factors that increase cellular potassium uptake, in addition to total body depletion of potassium due to renal, gastrointestinal, or sweat losses. Similarly hyperkalemia may be caused by redistribution of potassium from the intracellular to the extracellular fluid due to factors that impair cellular uptake of potassium, in addition to retention of potassium due to decreased renal excretion. An understanding of the drugs that affect potassium homeostasis, either by altering the renal excretion of potassium or by modifying its distribution, is essential to the proper assessment of many clinical potassium abnormalities. Both hypokalemia and hyperkalemia may cause asymptomatic electrocardiographic changes, serious arrhythmias, muscle weakness, and death. Hypokalemia has also been associated with several other consequences, including postural hypotension, potentiation of digitalis toxicity, confusional states, glucose intolerance, polyuria, metabolic alkalosis, sodium retention, rhabdomyolysis, intestinal ileus, and decreased gastric motility and acid secretion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6388326     DOI: 10.1016/s0002-9343(84)80002-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

Review 1.  Correction of hyponatremia and osmotic demyelinating syndrome: have we neglected to think intracellularly?

Authors:  Phuong-Mai T Pham; Phuong-Anh T Pham; Son V Pham; Phuong-Truc T Pham; Phuong-Thu T Pham; Phuong-Chi T Pham
Journal:  Clin Exp Nephrol       Date:  2014-08-24       Impact factor: 2.801

2.  Significance of serum potassium level monitoring during the course of post-operative rehabilitation in patients with hypokalemia.

Authors:  Guanzhen Lu; Lingfang Xu; Yan Zhong; Ping Shi; Xuhui Shen
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

3.  Clustering out-of-hospital cardiac arrest patients with non-shockable rhythm by machine learning latent class analysis.

Authors:  Yohei Okada; Sho Komukai; Tetsuhisa Kitamura; Takeyuki Kiguchi; Taro Irisawa; Tomoki Yamada; Kazuhisa Yoshiya; Changhwi Park; Tetsuro Nishimura; Takuya Ishibe; Yoshiki Yagi; Masafumi Kishimoto; Toshiya Inoue; Yasuyuki Hayashi; Taku Sogabe; Takaya Morooka; Haruko Sakamoto; Keitaro Suzuki; Fumiko Nakamura; Tasuku Matsuyama; Norihiro Nishioka; Daisuke Kobayashi; Satoshi Matsui; Atsushi Hirayama; Satoshi Yoshimura; Shunsuke Kimata; Takeshi Shimazu; Shigeru Ohtsuru; Taku Iwami
Journal:  Acute Med Surg       Date:  2022-05-27

Review 4.  Potassium and anaesthesia.

Authors:  J E Tetzlaff; J F O'Hara; M T Walsh
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

Review 5.  Fluid, electrolyte and acid-base disorders associated with antibiotic therapy.

Authors:  R Zietse; R Zoutendijk; E J Hoorn
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

6.  A comparison of the effect of lisinopril and hydrochlorothiazide on electrolyte balance in essential hypertension.

Authors:  D B Frewin; R C Bartholomeusz; R D Gaffney; A D Clampett; B E Chatterton
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 7.  Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence.

Authors:  A W Hoes; D E Grobbee; T M Peet; J Lubsen
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

8.  Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial.

Authors:  Bertram Pitt; Stefan D Anker; David A Bushinsky; Dalane W Kitzman; Faiez Zannad; I-Zu Huang
Journal:  Eur Heart J       Date:  2011-01-05       Impact factor: 29.983

9.  Predictive accuracy of biomarkers for survival among cardiac arrest patients with hypothermia: a prospective observational cohort study in Japan.

Authors:  Yohei Okada; Takeyuki Kiguchi; Taro Irisawa; Kazuhisa Yoshiya; Tomoki Yamada; Koichi Hayakawa; Kazuo Noguchi; Tetsuro Nishimura; Takuya Ishibe; Yoshiki Yagi; Masafumi Kishimoto; Hiroshi Shintani; Yasuyuki Hayashi; Taku Sogabe; Takaya Morooka; Haruko Sakamoto; Keitaro Suzuki; Fumiko Nakamura; Norihiro Nishioka; Tasuku Matsuyama; Satoshi Matsui; Takeshi Shimazu; Kaoru Koike; Takashi Kawamura; Tetsuhisa Kitamura; Taku Iwami
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2020-08-05       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.